ERAS Program Implementation for MIPD

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jun 3, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how an Enhanced Recovery After Surgery (ERAS) program can help patients recover after undergoing a specific type of surgery called minimally invasive pancreatoduodenectomy (MIPD). This surgery is typically performed to treat tumors near the pancreas. The goal of the trial is to see if following the ERAS program can improve recovery times and overall outcomes for patients who have this surgery.

To be eligible for the study, participants need to be at least 19 years old and scheduled for MIPD. They should be in good health (with a performance status of 0 or 1) and able to understand the study procedures. Importantly, they should not have certain medical conditions or allergies that would prevent them from participating. If someone joins the study, they can expect to follow specific recovery guidelines and complete some questionnaires about their experience. This trial is not yet recruiting, so if you or someone you know is interested, it’s a good idea to stay informed for when it begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 19 years, scheduled for standard minimally invasive (robotic or laparoscopic) pancreatoduodenectomy for periampullary tumors
• • ECOG performance status of 0 or 1 at screening
• • Able to provide written informed consent, understand study procedures, and complete patient-reported questionnaires
• • ASA physical status classification I-III
• Exclusion Criteria:
• • Hypersensitivity to fentanyl or ropivacaine
• • Cognitive impairment preventing independent use of patient-controlled analgesia or completion of questionnaires
• • Major internal medical or psychiatric disorders affecting treatment response
• • Severe hepatic or renal dysfunction
• • Any condition deemed inappropriate for study participation by the investigator